Showing results (101-110 of 219) with videos related to
Sort By:
Pageof 22
Radiology|September 23, 2014
Perfusion CT for selecting patients with acute ischemic stroke for intravenous thrombolytic therapyKirsteen R Burton, Deljit Dhanoa, Richard I Aviv, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 6, 2006
Changes in rates of upper gastrointestinal hemorrhage after the introduction of cyclooxygenase-2 inhibitors in British Columbia and OntarioMuhammad Mamdani, Leanne Warren, Alex Kopp, et al.Plos One|March 6, 2013
The timing of drug funding announcements relative to elections: a case study involving dementia medicationsSudeep S Gill, Neeraj Gupta, Chaim M Bell, et al.Stroke|April 14, 2020
Association Between Immigration Status and Acute Stroke Care: A Retrospective StudyManav V Vyas, Andreas Laupacis, Peter C Austin, et al.Journal of the American Society of Nephrology : JASN|June 10, 2015
Immune Sensitization and Mortality in Wait-Listed Kidney Transplant CandidatesRuth Sapir-Pichhadze, Kathryn J Tinckam, Andreas Laupacis, et al.Annals of Emergency Medicine|February 1, 2017
A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrestGraham Nichol, Ian G Stiell, Andreas Laupacis, et al.CMAJ Open|April 13, 2017
Development of a preliminary essential medicines list for CanadaMichael S Taglione, Haroon Ahmad, Morgan Slater, et al.CMAJ Open|July 12, 2016
Predictors of diagnostic neuroimaging delays among adults presenting with symptoms suggestive of acute stroke in Ontario: a prospective cohort studyKirsteen R Burton, Moira K Kapral, Shudong Li, et al.Journal of Evaluation in Clinical Practice|December 21, 2005
Diabetic patients with prior specialist care have better glycaemic control than those with prior primary careBaiju R Shah, Janet E Hux, Andreas Laupacis, et al.American Journal of Clinical Oncology|July 12, 2012
Randomized feasibility study of de-escalated (every 12 wk) versus standard (every 3 to 4 wk) intravenous pamidronate in women with low-risk bone metastases from breast cancerEitan Amir, Orit Freedman, Lindsay Carlsson, et al.Pageof 22